Epidural Analgesia in Lung Transplant Patients


TITLE: Epidural analgesia in Lung Transplant Patients
AUTHORS: G Mund, MD, S Dogra, MD, L Lucas, MD,
WS Blau, MD, PhD, P Calhoun, RN
AFFILIATION: Department of Anesthesiology, University of North Carolina, Chapel
Hill NC 27599-7010
We carried out a retrospective survey of 35 single lung transplant(SLT) and
sequential double lung transplant (DLT) patients to assess the efficacy and side
effects of epidural analgesia in the management of postoperative pain. A
previous literature review and a MEDLINE search revealed little information on
the management of postoperative pain in this unique subgroup of patients.
In our institution there have been 101 single and double lung transplants in 95
patients since the inception of the program in 1990. The initial group of
patients had postop pain managed with intravenous bolus or patient controlled
analgesia techniques using morphine. Postoperative epidural analgesia was
gradually introduced from 1991 onwards. A review of the lung transplant registry
had 35 patients who used epidurals for pain management. These charts were
reviewed for patient demographics, time of surgery and extubation times,
placement of epidural, efficacy of epidural analgesia and side effects
attributable to the drugs or techniques used. Site of epidural placement,
incision site and duration of epidural use was also noted.
The majority of patients had a preoperative diagnosis of cystic fibrosis. The
average age was 32.10 yrs (range 4.83 to 55yrs) and average weight was 50.10kg
(range 18.6 to 81kg). There were 10 single lung and 25 sequential double lung
transplants. The SLTıs underwent a lateral thoracotomy incision as compared to
the DLT patients who had a bilateral thoracotomy and transverse sternotomy
incision (³clam-shell² incision).
In 7/35 cases epidurals were placed preoperatively (day 0) and 28/35 patients
had the epidurals placed postoperatively on day 0.81(range 0.81 to 2.9) from day
of surgery. The patients were extubated at an average 1.46(range 0.4 to 4.75)
days after surgery . Coagulation studies (prothrombin time, activated clotting
time, and platelet count >100,000 ) were near normal in all cases when the
epidurals were placed. Abnormal coag screens led to late placement of epidural
catheters. The catheters were placed at the site of easiest access with the
median being T9 (range T4 -L4). The duration of use of the epidural catheter was
for an average of 3.76(range 0.5 to 7) days. The analgesics used through the
epidural included fentanyl, fentanyl bupivacaine mixtures, and morphine sulfate.
The techniques of administration included continuous infusion and PCA mode for
fentanyl infusions, continuous infusions for fentanyl/bupivacaine mixtures, and
continuous or bolus methods for epidural morphine. Sedative and anxiolytic drugs
were used when indicated and included chloral hydrate, haldol and lorazepam.
Side effects were minor and included pain, pruritus and sedation. The dosages of
the analgesic agents were frequently adjusted with a bolus of the epidural agent
being given when indicated for better pain control. There were 7/35 patients who
needed additional analgesia to control pain with small doses of iv opioids.
There were 20 patients who required sedative or anxiolytic drugs. There were
9/20 cases of mild respiratory depression and sedation in this group of
patients.
There is a paucity of information available on using epidural analgesia in post
lung transplant patients. This is a unique group of patients with extensive
surgical incisions and significant postoperative pain who need effective
analgesia to avoid pulmonary complications in the postoperative period.
Effective analgesia also allows early extubation in these patients with the
ability to cooperate with respiratory therapy.
Our study showed that time to extubation after epidural catheter placement was
0.65days ( average range 0.4 to 1.85) days. At our institution, postoperative
epidural analgesia in lung transplant patients has been found to be a useful
method of providing effective pain relief in the critical postoperative period
of this group of patients with a low complication rate. We believe that epidural
analgesia is safe and effective in producing good pain control with minimal side
effects in post lung transplant patients.
References
1. Scand J Thor Cardiovasc Surg 26:163-168, 1992.
2. J Cardiothor Vascular Anes 7:5, 1993, 529-534.
3. Pain control after thoracotomy by Katz.


TITLE: EPIDURAL ANALGESIA COMPARED WITH IVPCA IN LUNG TRANSPLANT PATIENTS
AUTHORS: S Dogra, MD, WS Blau, MD, PhD, W Lucas, MD, P Calhoun, RN
AFFILIATION: Department of Anesthesiology, University of North Carolina, Chapel
Hill NC 27599-7010
Introduction. A literature review and a MEDLINE search1,2 revealed little
information on the management of postoperative pain in the unique subgroup of
patients undergoing lung transplantation. We analyzed our database and reviewed
records of 55 single lung transplant (SLT) and bilateral sequential double lung
transplant (DLT) patients to assess the efficacy and side effects of
postoperative analgesia in this unique group of individuals.
Methods. Analysis of the records revealed 35 patients who received epidurals
and these were compared to 20 patients who had morphine infusions via
intravenous patient controlled analgesia (IVPCA) pumps for postoperative pain
management. These were reviewed for patient demographics, time of surgery and
extubation times, placement of epidural, efficacy of analgesia, and side effects
attributable to the drugs or techniques used. Site of epidural placement,
incision site, and duration of postoperative utilization of the analgesic
technique were also noted.
Results. The majority of patients had a preoperative diagnosis of cystic
fibrosis and patient demographics in the two groups were similar. The 16 SLTıs
underwent a lateral thoracotomy incision as compared to the 39 DLT patients who
had a bilateral thoracotomy and transverse sternotomy incision (³clam-shell²
incision). Coagulation studies were near normal in all cases when the epidurals
were placed and if abnormal led to the late placement of some epidurals. The
epidural catheters were placed preoperatively (7/35) and postoperatively (28/35)
at the site of easiest access with the median being T8 (range T4 -L4). The
analgesics used through the epidural included fentanyl, fentanyl bupivacaine
mixtures and morphine sulfate. The IVPCA was started soon after surgery and
morphine was the drug most commonly used. Duration of analgesia use was 3.76
days in the epidural group vs. 6.00 days in the IVPCA group, until the patients
were converted to oral medications. Sedative and anxiolytic drugs were used
when indicated and included chloral hydrate, haldol and lorazepam. Patients in
the epidural group were extubated 1.46 days on average after surgery as compared
to 3.49 days on average in the IVPCA group.
Side effects were minor and included pain, pruritus and sedation. There were
20/35 patients with epidurals who needed sedative/anxiolytic drugs compared with
14/20 in the IVPCA group. Reintubation rates differed with 10/35 (29%) in the
epidural group and 11/20 (55%) in the IVPCA group. Mortality rates were 3/35
(9%) in the epidural patients and 4/20 (20%) in the IVPCA patients.
Discussion. There is a surprising lack of information available on optimal
analgesic techniques in post lung transplant patients. This is a unique group
of patients with extensive surgical incisions and significant postoperative pain
needs. Effective analgesia allows early extubation and may help to avoid
reintubation. This may impact on mortality rates though our study did not look
at the large number of other variables that will ultimately impact on mortality.
The early use of epidural analgesia may serve as a marker of a successful
outcome subsequently. Our study showed a trend towards shorter time to
extubation and avoidance of reintubation in patients with epidurals. We believe
that epidural analgesia is a safe and effective technique in providing
satisfactory pain control with minimal side effects in post lung transplant
patients.
References
1. Medline
2. Scand J Thor Cardiovasc Surg 26:163-168, 1992.